圣诺生物:2021年第三季度报告

奥园美谷：2021年第三季度报告

艾媒舆情|2020年315晚会“可诺丹婷虚假广告”问题曝光舆情监测报告

2020年7月16日，央视在3·15晚会曝光了可诺丹婷美容院存在以“免费”噱头推销高价美容项目、以“连环计”设套诱导学生消费、以格式条款及其他借口拒绝消费者退款等涉嫌违法行为。当晚，可诺丹婷美容院发表声明称，已立即要求涉事门店停业整顿，并已成立专项工作小组跟进此事。

艾媒咨询|2020上半年中国医疗美容行业趋势研究报告

本报告研究涉及企业/品牌/案例：美团医美、新氧。

受颜值经济影响，医疗美容市场异常火热，自2013年以来，中国医疗美容市场规模便保持持续增长趋势，预计2020年中国医疗美容用户规模达1520万人。随着医美消费意识的进一步觉醒、供给的持续增长和“互联网+医美”模式的渗透，未来医美行业的用户规模将继续增长。iiMedia Research（艾媒咨询）调研数据显示，六成用户理解支持医美消费，而目前线下医美机构仍然是消费者获取医美信息的主要渠道，其次是网络社交平台以及互联网医美平台。互联网医美平台的渗透率提升及内容化趋势，将有效推动行业资源的进一步整合，专业医美平台未来或将成为消费者了解及鉴别医美信息的重要窗口。美团医美、新氧等互联网医疗美容平台为医美行业新生态建设起到推动作用。互联网医疗美容平台的出现，以其低廉的佣金和可靠的垂直搜索特性在一定程度上帮助医美行业吸引更多消费者，拓展了获客渠道。未来医美机构将更加注重调整自身的营销策略，借助互联网平台等新手段更加精准的进行用户挖掘和服务扩散。

Affected by the beauty economy, the medical beauty market is extremely hot. Since 2013, the size of China's medical beauty market has maintained a continuous growth trend. It is estimated that the number of Chinese medical beauty users will reach 15.2 million in 2020. With the further awakening of medical aesthetics consumption awareness, continuous growth in supply and the penetration of the "Internet and medical aesthetics" model, the user scale of the medical aesthetics industry will continue to grow in the future. As the data of iiMedia Research showed, Sixty percent of users understand that they support the consumption of medical beauty, and offline medical beauty institutions are still the main channels for consumers to obtain medical beauty information, followed by online social platforms and Internet medical beauty platforms. The penetration rate and content trend of Internet medical aesthetics platforms will effectively promote the further integration of industry resources. In the future, professional medical aesthetics platforms may become an important window for consumers to understand and identify medical aesthetics information. Internet medical cosmetology platforms such as Meituan Medical Beauty and So Young have played a role in promoting the construction of a new ecology in the medical cosmetology industry. The emergence of the Internet medical cosmetology platform, with its low commissions and reliable vertical search features, has helped the medical cosmetology industry to attract more consumers to a certain extent and expanded the customer acquisition channels. In the future, medical aesthetic institutions will pay more attention to adjusting their own marketing strategies, and accurately conduct user data mining and service diffusion.

艾媒报告|2019年中国轻医美消费趋势研究报告

本报告研究涉及企业/品牌/案例：飞顿医疗激光公司，奇致激光，Lumenis，CANDELA，华西生物，Allergan，昊海生物科技，中国生物兰州生物制品研究所有限责任公司，上海九院，北京八大处，四川华西，小红书，百度，微信，新氧，更美，悦美，美团，阿里健康

当前，中国轻医美市场供需迎来双增长，轻医美市场逐渐崛起。iiMedia Research(艾媒咨询)数据显示，预计2020年中国轻医美市场用户规模将达到1520万人。便捷、安全成轻医美消费重要推力，随着轻医美消费意识日益提升，轻医美或成中国消费者求美的“第一选择”。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展。医美机构加速拓展轻医美业务，轻医美诊所应运而生。与此同时，轻医美医生在流程操作、药械使用上更易实现规模化培养。在行业支持体系方面，互联网医美平台助推轻医美加速数字化升级，市场管理提效规范行业发展。在此背景下，中国轻医美消费市场迎来更好的发展空间。纵观当前中国轻医美消费新态势，供需协同并进以及行业支持体系日益完善，轻医美消费已逐渐成为求美新主流。

At present, the supply and demand of China's light medical beauty market is experiencing double growth, and the light medical beauty market is gradually rising. According to iiMedia Research, it is estimated that the user scale of China's light medical beauty market will reach 15.2 million in 2020. Convenience and safety have become an important driving force for the consumption of light medical beauty. With the increasing consumer awareness of light medical beauty, light medical beauty or become the “first choice“ for Chinese consumers seeking beauty. Driven by the awakening of consumer consciousness and consumer demand, institutions and doctors have strongly boosted the rapid development of the light medical beauty industry on the supply side. Medical beauty institutions to accelerate the expansion of light medical beauty business, light medical beauty clinic came into being. At the same time, it is easier for doctors to realize large-scale cultivation in process operation and medical device use. In terms of the industry support system, the Internet medical beauty platform promotes the digitalization and upgrading of medical beauty, and market management improves the efficiency and standardizes the development of the industry. In this context, China's light medical beauty consumer market usher in a better space for development. In view of the new trend of China's light medical beauty consumption, the coordinated development of supply and demand and the increasingly perfect industry support system, light medical beauty consumption has gradually become the new mainstream of seeking beauty.

艾媒咨询｜2024年中国生活美容及轻医美市场研究报告

随着居民生活水平的提高和审美观念的转变，美容行业逐渐形成一个庞大的产业链，从基本的护肤、化妆到整形、微整形等，美容行业的服务范围越发广泛。全球新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2024年中国生活美容及轻医美市场研究报告》数据显示，2023年中国美容行业市场规模已达2804.0亿元，预计2025年市场规模有望达到3816.0亿元。未来，科技美容将成为美容行业的一个重要发展方向。数据显示，2017-2023年间中国轻医美市场用户规模不断增长，2023年其用户规模达2354万人，预计到2025年将达3105万人。用户规模的持续增长，表明中国轻医美市场呈现快速发展趋势，整个市场仍有巨大的发展潜力。
With the improvement of residents' living standards and the change of aesthetic concepts, the beauty industry has gradually become a huge industrial chain, from basic skin care, makeup to plastic surgery, micro-plastic surgery, etc., the service range of the beauty industry is more and more extensive. According to the latest "China Life Beauty and light Medicine Beauty Market Research Report 2024" released by iiMedia Research, a third-party data mining and analysis institution in the global new economy industry, the market size of China's beauty industry has reached 280.04 billion yuan in 2023. It is expected that the market size is expected to reach 381.60 billion yuan in 2025. In the future, science and technology beauty will become an important development direction of the beauty industry. Data show that the user scale of China's light medical beauty market continues to grow between 2017 and 2023, with the user scale reaching 23.54 million in 2023 and is expected to reach 31.05 million in 2025. The continuous growth of the user scale indicates that China's light medical beauty market is showing a rapid development trend, and the entire market still has huge development potential.

艾媒咨询|2021年中国医美机构市场竞争态势及企业营销模式分析报告

本报告研究涉及企业/品牌/案例：华韩整形，瑞丽医美，美莱整形，医思健康

数据显示，2016—2020年中国医美行业市场规模五年平均增长率为12.8%，与此同时，中国医美市场用户规模增长了4倍多。在人们生活水平的提升、年轻一代对医美的接受度的提高、政府监管层对医美行业的整治给医美消费者信心的提升的综合作用下，预计中国医美市场规模在2022年将达到2232亿元。随着医美产品及仪器技术水平提升、医美知识普及等，民众对整形美容的观念正在向积极态度转变，在整个行业扩张的过程中，轻医美的受众面广、门槛低、复购率高，更有可能提升市场整体渗透率，成为我国医美行业的主要增量市场。
According to the data, from 2016 to 2020, the five-year average growth rate of the market scale of China's medical and American industry was 12.8%. At the same time, the user scale of China's medical and American market increased by more than four times. Under the combined effect of the improvement of people's living standards, the improvement of the acceptance of medical beauty by the younger generation, the regulation of the medical beauty industry by the government regulators and the improvement of medical beauty consumer confidence, it is expected that the scale of China's medical beauty market will reach 223.2 billion yuan in 2022. With the improvement of the technical level of medical beauty products and instruments and the popularization of medical beauty knowledge, people's concept of plastic beauty is changing to a positive attitude. In the process of the expansion of the whole industry, light medical beauty has a wide audience, low threshold and high repurchase rate, which is more likely to improve the overall penetration rate of the market and become the main incremental market of China's medical beauty industry.

艾媒咨询 | 2025年中国医美行业发展状况与消费行为调查数据

随着消费升级与技术迭代，中国医美行业已从传统整形扩展至轻医美、抗衰老等多元化领域，市场规模持续扩大。根据全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国医美行业发展状况与消费行为调查数据》显示，2025年中国医美服务行业市场规模为3701亿元，2025年中国轻医美市场用户规模达3105万人。中国医美市场的增长不仅源于消费升级，也得益于技术普惠与轻医美项目的高复购率。当前行业已进入以精细化运营、差异化服务和合规化发展为核心驱动的新阶段。
在2025年中国消费者对医美项目的接受程度中，“会考虑整形，但风险要相对可控”位列第一，占比46.02%；其次是“能够接受手术医美整形，并承受一定风险”，占比22.94%。此外，在消费者接受过的医美项目中，轻医美（非手术类）占比最高，达到74.45%；医美整形（手术类）的占比为33.52%。这表明中国消费者对医美的态度趋于理性与谨慎，安全可控的非手术类项目成为市场主流偏好。同时，手术类项目亦拥有稳定的需求群体，显示出市场需求的层次性与多元化。
艾媒咨询分析师认为，未来中国医美市场将延续“轻医美主导、技术驱动、合规深化”的主线发展。一方面，非手术项目凭借低风险、高复购优势，仍是增长核心，Z世代与男性、下沉市场需求进一步释放。另一方面，再生材料、AI个性化方案及智能器械加速迭代，推动服务精准化与效果革新。此外，监管常态化下，行业加速品牌化整合，合规机构与上游技术型企业凸显优势。总的来说，消费者更趋理性，追求自然效果与安全保障，倒逼市场从营销竞争转向以品质、精细化运营为核心的高质量发展新阶段。
With the upgrading of consumption and technological advancements, China's medical aesthetics industry has expanded from traditional plastic surgery to diversified fields such as minimally invasive aesthetics and anti-aging. The market size has continued to grow. According to the latest "2025 China Medical Aesthetics Industry Development Status and Consumer Behavior Survey Data" released by iiMedia Research, a leading third-party data mining and analysis institution for the new economy industry, the market size of China's medical aesthetics service industry will reach 370.1 billion yuan in 2025, and the user scale of the minimally invasive aesthetics market in China will reach 31.05 million people in 2025. The growth of China's medical aesthetics market is not only due to the upgrading of consumption but also benefits from the popularization of technology and the high repurchase rate of minimally invasive aesthetics projects. Currently, the industry has entered a new stage driven by refined operation, differentiated services, and compliance development.
In terms of Chinese consumers' acceptance of medical aesthetics projects in 2025, "Would consider plastic surgery, but the risk should be relatively controllable" ranks first, accounting for 46.02%; followed by "Can accept surgical medical aesthetics and bear certain risks", accounting for 22.94%. Additionally, among the medical aesthetics projects consumers have received, minimally invasive aesthetics (non-surgical) accounts for the highest proportion, reaching 74.45%; surgical medical aesthetics accounts for 33.52%. This indicates that Chinese consumers' attitudes towards medical aesthetics are becoming more rational and cautious, and non-surgical projects with low risks and high repurchase rates have become the mainstream preference in the market. At the same time, surgical projects also have a stable demand group, demonstrating the hierarchical and diversified nature of market demand.
Analysts from iiMedia Research believe that in the future, China's medical aesthetics market will continue to develop along the main line of "minimally invasive aesthetics dominance, technology-driven, and compliance deepening". On the one hand, non-surgical projects, with their low-risk and high-repurchase advantages, will remain the core of growth, and the demands of Generation Z, men, and consumers in lower-tier cities will be further released. On the other hand, regenerative materials, AI personalized solutions, and intelligent devices will accelerate iteration, promoting the precision and effect innovation of services. Moreover, under the normalization of regulation, the industry will accelerate brand integration, and compliant institutions and upstream technology enterprises will highlight their advantages. In summary, consumers are becoming more rational, pursuing natural effects and safety guarantees, which will force the market to shift from marketing competition to high-quality development centered on quality and refined operation.

艾媒报告 |2018-2019中国医疗美容行业研究与产业链分析报告

本报告研究涉及企业/品牌包括:新氧、更美、悦美、美黛拉、美丽神器、美呗、南方医院、伊美尔、熙朵、碧莲盛、雍禾植发、科发源植发、新生植发、恒博医疗、昊海生物科技、华熙生物、复星医药、深圳鹏爱医疗美容医院、北京丽都医疗美容医院

中国医疗美容行业处于快速发展期，iiMedia Research（艾媒咨询）监测发现，2018年中国医美行业市场规模达2245亿元，牙齿美容及面部美容是医美市场的重要构成部分，占比分别达32.5%和35.3%。目前中国医美行业已形成生产商、医美机构、终端市场三大产业链环节，产业发展前景广阔，但作为新兴行业，中国医疗美容行业将面临着行业监管、公共关系危机、行业竞争激烈等几大风险。

Driven by the rise of the younger generation of consumer groups and the development of new models in the medical beauty industry, the penetration rate and consumer demand of China's medical beauty industry continue to rise. In 2018, the penetration rate of Chinese medical users reached 7.4%, and women were the main medical and aesthetic consumers. The proportion is 88.9%. At present, there are more than 10,000 registered medical and beauty institutions in China, and the industry is in a period of rapid development. iiMedia Research found that embedding, double eyelids, and full body fat filling are the favorite surgical items for Chinese women and medical consumers, while nasal synthesis, tautological fat, cheeks, hair transplants, etc. For the Chinese male medical beauty consumer's favorite surgical project, potential customers in China's medical beauty industry are most concerned about the safety of surgery, followed by medical qualifications and word of mouth and surgery prices. Medical beauty as an emerging industry, public relations crisis, strict industry supervision, lack of relevant professionals is a factor that restricts its development, and in the future, with the influx of capital from the industry, the competition in China's medical and aesthetic industry will become more intense.

艾媒咨询｜2021年中国美容美发行业投资机遇及总体趋势研究报告

数据显示，2015-2021年中国美容美发行业市场规模复合增长率为4.0%，2021年市场规模为3863亿元。随着国民生活水平的提高以及对生活品质的不断追求，美容美发业的消费需求旺盛，上下游产业和新兴业态快速发展，预估2022年中国美容美发行业市场规模将突破4000亿元。且值得注意的是，在备案完善、监督加强及违法经营成本提升的背景下，中国化妆品行业将加速整顿，有效保障产品安全及其功效的稳定性，具有较强研发实力的品牌有望占据更大的市场份额。随着新消费群体逐渐成为购买主力，不能快速响应市场的品牌面临淘汰，大规模企业兼并即将到来。
According to the data, the compound growth rate of the market scale of China's beauty salon industry from 2015 to 2021 was 4.0%, and the market scale in 2021 was 386.3 billion yuan. With the improvement of national living standards and the continuous pursuit of quality of life, the consumption demand of beauty salon industry is strong, and the upstream and downstream industries and emerging business forms are developing rapidly. It is estimated that the market scale of China's beauty salon industry will exceed 400 billion yuan in 2022. It is worth noting that under the background of perfect filing, strengthened supervision and increased illegal operating costs, China's cosmetics industry will accelerate the rectification and effectively ensure the stability of product safety and efficacy. Brands with strong R & D strength are expected to occupy a larger market share. As new consumer groups gradually become the main force of purchase, brands that cannot respond quickly to the market are facing elimination, and large-scale enterprise mergers are coming.